Crest, Oral-B Pro-Health Clinical line takes aim at plaque
Crest and Oral-B have added the Pro-Health Clinical Plaque Control line of products, which are designed to significantly reduce plaque when used together.
Supplier News
Novartis releases Arcapta Neohaler for COPD
Novartis Pharmaceuticals Corp. has shipped once-daily Arcapta Neohaler (indacaterol inhalation powder) 75 mcg to pharmacies nationwide.
Mederma debuts advanced scar treatment
Merz Pharmaceuticals has introduced Mederma Advanced Scar Gel, billed as the first and only once-daily topical scar gel clinically shown to reduce the appearance of scars.
Studies highlight efficacy of Olay body moisturizers
New research has found that two Olay body moisturizing formulas with niacinamide provide rapid, lasting dry skin benefits over conventional moisturizers.
AmLactin campaign to feature cosmetic dermatologist
Upsher-Smith Laboratories’ AmLactin Alpha-Hydroxy Skin Care brand has signed New York cosmetic dermatologist Dr. Doris Day to serve as an educational consultant for its "Ultra Skin Performance" campaign.
Teva ships generic of Lexapro
Teva Pharmaceutical Industries Ltd. has begun the commercial launch of escitalopram oxalate tablets, an antidepressant medication. Teva said Wednesday that its product is a generic version of Forest Laboratories’ Lexapro Tablets.
H.D. Smith appoints CFO
H.D. Smith has made Bill Williams its permanent chief financial officer after he recently served in the post on an interim basis. The pharmaceutical distributor said Wednesday that as CFO Williams joins the executive committee and reports to chairman and chief executive officer Dale Smith.
Medline unveils FitRight incontinence products
Medline Industries Inc. has introduced its FitRight line, which the company said represents "entirely new kind of adult incontinence product." The company said Monday that FitRight reinvents how incontinence products look, feel and perform, helping people with incontinence live with confidence.
Prestige Brands gives thumbs-down to Genomma bid
The board of directors of Prestige Brands Holdings Inc. has unanimously rejected an unsolicited bid by Genomma Lab Internacional S.A.B. de C.V. to buy the company.
PepsiCo hires ex-Sam’s Club CEO in leadership realignment
PepsiCo Inc. has named former Sam’s Club president and chief executive officer Brian Cornell to serve as president of PepsiCo America Foods.
EyeScience unveils eye vitamin for diabetics
EyeScience Labs has developed Diabetic Vision Formula, a new eye vitamin for people with diabetes. EyeScience said Tuesday that the new product is designed to help protect against potential vision problems related to diabetic retinopathy, a condition that affects about 4.
Fera adds new ophthalmic anti-infective
Fera Pharmaceuticals has introduced Sulfacetamide Sodium Ophthalmic Ointment 10%, used to treat superficial ocular infections, including conjunctivitis. Fera said Tuesday that Sulfacetamide, in ointment form, will be an important addition to physicians’ treatment armamentarium.
Watson releases Prometrium generic
Watson Pharmaceuticals Inc. has begun shipping an authorized generic version of Prometrium capsules. The company said Friday that its product, progesterone capsules in 100mg and 200mg dosages, were launched as part of an agreement with Abbott Laboratories.
Perrigo launches generic Rogaine foam
Perrigo Co. has begun rolling out minoxidil 5% foam to its retail and wholesale customers. The company said Thursday that the product, marketed under store brands or own-label brands, is comparable to Rogaine 5% Foam Hair Regrowth Treatment.
McNamara named head of Novartis OTC unit
Novartis has appointed Brian McNamara as division head of Novartis OTC, the Swiss pharmaceutical giant’s over-the-counter products business unit. The company said late Wednesady that McNamara, who takes the post effective immediately, replaces Naomi Kelman, who is leaving the company.
Mylan introduces generic version of Lexapro
Mylan Inc. has launched escitalopram tablets, which the company said is the first equivalent product to Forest Laboratories’ Lexapro antidepressant. Mylan said Wednesday that its escitalopram product, released by its Mylan Pharmaceuticals Inc. subsidiary, comes in strengths of 5 mg, 10 mg and 20 mg.